Novel Treatment for Coronary Artery Disease
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.
Also called NCT01228214
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 100 participants
- Sponsor
- University of Carabobo
- Registry
-
NCT01228214
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Venezuela
- Registry status
- Unknown status
Technical summary
Registry record NCT01228214. Randomized; double masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2013-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Novel Treatment for Coronary Artery Disease
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- amiloride
- Lead sponsor
- University of Carabobo
- Collaborator
- Clinical Research Unit at the Instituto Docente de Urologia
- Collaborator
- Northern Metropolitan Hospital
- Collaborator
- Venezuelan Foundation of Heart Failure
Record details
- Record id
cardio:ct-nct01228214- Content hash
620b427b45b2d121e6c106f45546e8da00eba687c40f87aaa62915150d092b0a